Literature DB >> 8375340

Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice.

A Patapoutian1, J H Miner, G E Lyons, B Wold.   

Abstract

In developing mouse embryos, MyoD family regulatory genes are expressed specifically in muscle precursors and mature myofibers. This pattern, taken together with the well-established ability of MyoD family members to convert a variety of cell types to skeletal muscle, suggests a significant role for these genes in regulating skeletal myogenesis. The possibility that expression of these genes may be causally associated with segregation of the myogenic lineage from other mesodermal derivatives, or with the subsequent maintenance of muscle phenotypes at later times, raises the issue of how MyoD family genes are themselves regulated during development. In this work, we have initiated studies to identify DNA sequences that govern Myf-5 and MRF4 (herculin, myf-6) transcription. Myf-5 is the first of the MyoD family to be expressed in the developing mouse embryo, while MRF4 is the most abundantly expressed myogenic factor in postnatal animals. In spite of their strikingly divergent patterns of expression, Myf-5 and MRF4 are tightly linked in the mouse genome; their translational start codons are only 8.5 kilobases apart. Here, the 5' flanking regions of the mouse Myf-5 and MRF4 genes were separately linked to a bacterial beta-galactosidase (lacZ) gene, and these constructs were each used to produce several lines of transgenic mice. Transgene expression was monitored by X-gal staining of whole embryos and by in situ hybridization of embryo sections. For the Myf-5/lacZ lines, the most intense transgene expression was in the visceral arches and their craniofacial muscle derivatives, beginning at day 8.75 post coitum (p.c.). This correlates with endogenous Myf-5 expression in visceral arches.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375340     DOI: 10.1242/dev.118.1.61

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  20 in total

1.  Pre-selection of integration sites imparts repeatable transgene expression.

Authors:  H Wallace; R Ansell; J Clark; J McWhir
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Pitx2 is an upstream activator of extraocular myogenesis and survival.

Authors:  Amanda L Zacharias; Mark Lewandoski; Michael A Rudnicki; Philip J Gage
Journal:  Dev Biol       Date:  2010-10-28       Impact factor: 3.582

3.  Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development.

Authors:  Natalia Moncaut; Joe W Cross; Christine Siligan; Annette Keith; Kevin Taylor; Peter W J Rigby; Jaime J Carvajal
Journal:  Development       Date:  2012-03       Impact factor: 6.868

4.  Skeletal myogenesis and Myf5 activation.

Authors:  Tanja Francetic; Qiao Li
Journal:  Transcription       Date:  2011-05

5.  A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles.

Authors:  F Spitz; M Salminen; J Demignon; A Kahn; D Daegelen; P Maire
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 6.  Size matters: use of YACs, BACs and PACs in transgenic animals.

Authors:  P Giraldo; L Montoliu
Journal:  Transgenic Res       Date:  2001-04       Impact factor: 2.788

7.  Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull.

Authors:  Y H Liu; R Kundu; L Wu; W Luo; M A Ignelzi; M L Snead; R E Maxson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 8.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage.

Authors:  Constance Tom Noguchi; Li Wang; Heather M Rogers; Ruifeng Teng; Yi Jia
Journal:  Expert Rev Mol Med       Date:  2008-12-01       Impact factor: 5.600

9.  Molecular evolution of the MyoD family of transcription factors.

Authors:  W R Atchley; W M Fitch; M Bronner-Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice.

Authors:  M Salminen; S López; P Maire; A Kahn; D Daegelen
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.